Who owns ANBIO BIOTECHNOLOGY?
- Ticker: NNNN
- CUSIP Number: g0367b105
Tip: Access positions for across all investors
Analyze quarterly positions in Anbio Biotechnology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Anbio Biotechnology stock
Who bought or sold ANBIO BIOTECHNOLOGY this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 26k | $775k | 0% | Dec 2025 |
|
| Millennium Management | 7.1k | $264k | 100% | Sep 2025 |
|
| UBS Group | 2.8k | $86k | 197% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.0k | $30k | -59% | Dec 2025 |
|
| Wells Fargo & Company | 100.00 | $3.0k | 0% | Dec 2025 |
|
Who sold out of Anbio Biotechnology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Marshall Wace | Sep 2025 | 10k | $389k |
| XTX Topco | Sep 2025 | 6.9k | $257k |
| Hrt Financial | Sep 2025 | 6.0k | $223k |